A carbohydrate-rich diet reduces LDL size in QQ homozygotes for the Gln192Arg polymorphism of the paraoxonase 1 gene

Lipids

Volumn 40, Issue 5, 2005, Pages 471-476

  Delgado Lista, J ^a   Perez Jimenez, F ^a   Gavilan, E ^a   Marin, C ^a   Fuentes, F ^a   Fernandez Puebla, R A ^a   Perez Martinez, P ^a   Paniagua, J A ^a   Aguilera, C ^a   Lopez Miranda, J ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANTS; CARBOHYDRATES; ENZYMES; OXIDATION; SATURATION (MATERIALS COMPOSITION);

CARDIOVASCULAR; HOMOZYGOTES; POLYMORPHISM;

GENES;

CARBOHYDRATE; LOW DENSITY LIPOPROTEIN;

ADULT; ALLELE; ARTICLE; CARBOHYDRATE DIET; CARDIOVASCULAR RISK; DIETARY INTAKE; DNA POLYMORPHISM; FEMALE; GENE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HOMOZYGOTE; HUMAN; HUMAN EXPERIMENT; LIPID OXIDATION; MALE; NORMAL HUMAN; PON 1 GENE;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ARGININE; ARYLDIALKYLPHOSPHATASE; DIETARY CARBOHYDRATES; DIETARY FATS; DIETARY FATS, UNSATURATED; FEMALE; GLUTAMINE; HOMOZYGOTE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 21344463986     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-005-1406-0     Document Type: Article

References (42)

1. Mackness, M.I., Arrol, S., and Durrington, P.N. (1991) Paraoxonase Prevents Accumulation of Lipoperoxides in Low-Density Lipoprotein, FEBS Lett. 286, 152-154.
2. Watson, A.D., Berliner, J.A., Hama, S.Y., La Du, B.N., Faull, K.F., Fogelman, A.M., and Navab, M. (1995) Protective Effect of High Density Lipoprotein Associated Paraoxonase. Inhibition of the Biological Activity of Minimally Oxidized Low Density Lipoprotein, J Clin. Invest. 96, 2882-2891.
3. Mackness, B., Mackness, M.I., Durrington, P.N., Arrol, S., Evans, A.E., McMaster, D., Ferrieres, J., Ruidavets, J.B., Williams, N.R., and Howard, A.N. (2000) Paraoxonase Activity in Two Healthy Populations with Differing Rates of Coronary Heart Disease, Eur. J. Clin. Invest. 30, 4-10.
4. Sutherland, W.H., Walker, R.J., de Jong, S.A., van Rij, A.M., Phillips, V., and Walker, H.L. (1999) Reduced Postprandial Serum Paraoxonase Activity After a Meal Rich in Used Cooking Fat, Arterioscler. Thromb. Vasc. Biol. 19, 1340-1347.
5. Neuman, M.P., Neuman, H.R., Durante Costas, F., Barrera, V. Tavella, M., Peterson, G., Veroni, H., and Neuman, J. (2000) Postprandial Increase of Lipid Peroxide Products Parallel Reduction of Antioxidant Enzyme Properties, Atheroscler. 151, 262.
6. Kudchodkar, B.J., Lacko, A.G., Dory, L., and Fungwe, T.V. (2000) Dietary Fat Modulates Serum Paraoxonase 1 Activity in Rats, J. Nutr. 130, 2427-2433.
7. Scacchi, R., Corbo, R.M., Rickards, O., and De Stefano, G.F. (2003) New Data on the World Distribution of Paraoxonase (PON1 Gln 192 → Arg) Gene Frequencies, Hum. Biol. 75, 365-373.
8. Serrato, M., and Marian, A.J. (1995) A Variant of Human Paraoxonase/Arylesterase (HUMPONA) Gene Is a Risk Factor for Coronary Artery Disease, J. Clin. Invest. 96, 3005-3008.
9. Mackness, B., Mackness, M.I., Arrol, S., Turkie, W., and Durrington, P.N. (1998) Effect of the Human Serum Paraoxonase 55 and 192 Genetic Polymorphisms on the Protection by High Density Lipoprotein Against Low Density Lipoprotein Oxidative Modification, FEBS Lett. 423, 57-60.
10. Mackness, M.I., Mackness, B., Durrington, P.N., Connelly, P.W., and Hegele, R.A. (1996) Paraoxonase: Biochemistry, Genetics and Relationship to Plasma Lipoproteins, Curr. Opin. Lipidol. 7, 69-76.
11. Wheeler, J.G., Keavney, B.D., Watkins, H., Collins, R., and Danesh, J. (2004) Four Paraoxonase Gene Polymorphisms in 11212 Cases of Coronary Heart Disease and 12786 Controls: Meta-Analysis of 43 Studies, Lancet 363, 689-695.
12. Perez-Jimenez, F., Lopez-Miranda, J., and Mata, P. (2002) Protective Effect of Dietary Monounsaturated Fat on Arteriosclerosis: Beyond Cholesterol, Atherosclerosis 163, 385-398.
13. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report, Circulation 106, 3143-3421.
14. Willett, W.C., Sacks, F., Trichopoulou, A., Drescher, G., Ferro-Luzzi, A., Helsing, E., and Trichopoulos, D. (1995) Mediterranean Diet Pyramid: A Cultural Model for Healthy Eating, Am. J. Clin. Nutr. 61, 1402S-1406S.
15. Desroches, S., and Lamarche, B. (2004) Diet and Low-Density Lipoprotein Particle Size, Curr. Atheroscler. Rep. 6, 453-460.
16. Perez-Martinez, P., Ordovas, J.M., Lopez-Miranda, J., Gomez, P., Marin, C., Moreno, J., Fuentes, F., Fernandez de la Puebla, R.A., and Perez-Jimenez, F. (2003) Polymorphism Exon 1 Variant at the Locus of the Scavenger Receptor Class B Type I Gene: Influence on Plasma LDL Cholesterol in Healthy Subjects During the Consumption of Diets with Different Fat Contents, Am. J. Clin. Nutr. 77, 809-813.
17. National Cholesterol Education Program (NCEP). (1994) Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II), Circulation 89, 1333-1445.
18. Human Nutrition Information Service, U.S. Department of Agriculture (1987) Composition of Foods, Agriculture Handbook No. 8, U.S. Government Printing Office, Washington, DC.
19. Varela, G. (1980) Tablas de Composition de Alimentos, Consejo Superior de Investigaciónes Científicas, Madrid.
20. Allain, C.C., Poon, L.S., Chan, C.S., Richmond, W., and Fu, P.C. (1974) Enzymatic Determination of Total Serum Cholesterol, Clin. Chem. 20, 470-475.
21. Fossati, P., and Prencipe, L. (1982) Serum Triglycerides Determined Colorimetrically with an Enzyme That Produces Hydrogen Peroxide, Clin. Chem. 28, 2077-2080.
22. 2, Clin. Chem. 29, 2026-2030.
23. Friedewald, W.T., Levy, R.I., and Fredrickson, D.S. (1972) Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge, Clin. Chem. 18, 499-502.
24. Riepponen, P., Marniemi, J., and Rautaoja, T., (1987) Immunoturbidimetric Determination of Apolipoproteins A-1 and B in Serum, Scand. J. Clin. Lab. Invest. 47, 739-744.
25. Krauss, R., and Blanche, P. (1992) Detection and Quantification of LDL Subfractions, Curr. Opin. Lipidol. 3, 377 (1992).
26. Esterbauer, H., Striegl, G., Puhl, H., and Rotheneder, M. (1989) Continuous Monitoring of in vitro Oxidation of Human Low Density Lipoprotein, Free Radic. Res. Commun. 6, 67-75.
27. Humbert, R., Adler, D.A., Disteche, C.M., Hassett, C., Omiecinski, C.J., and Furlong, C.E. (1993) The Molecular Basis of the Human Serum Paraoxonase Activity Polymorphism, Nat. Genet. 3, 73-76.
28. Moreno, J.A., Perez-Jimenez, F., Martin, C., Gomez, P., Perez-Martinez, P., Moreno, R., Bellido, C., Fuentes, F., and Lopez-Miranda, J. (2004) The Effect of Dietary Fat on LDL Size Is Influenced by Apolipoprotein E Genotype in Healthy Subjects, J. Nutr. 134, 2517-2522.
29. Gonzalez-Amieva, A., Lopez-Miranda, J., Fuentes, F., Castro, P., Marin, C., Lopez-Granados, A., Valles, F., and Perez-Jimenez, F. (2000) Genetic Variations of the Apolipoprotein E Gene Determine the Plasma Triglyceride Levels After Heart Transplantation, J. Heart Lung Transplant. 19, 765-770.
30. Ordovas, J.M., Lopez-Miranda, J., Mata, P., Perez-Jimenez, F., Lichtenstein, A.H., and Schaefer, E.J. (1995) Gene-Diet Interaction in Determining Plasma Lipid Response to Dietary Intervention, Atherosclerosis 118 (Suppl.), S11-S27.
31. Ordovas, J.M., Lopez-Miranda, J., Perez-Jimenez, F., Rodriguez, C., Park, J.S., Cole, T., and Schaefer, E.J. (1995) Effect of Apolipoprotein E and A-IV Phenotypes on the Low Density Lipoprotein Response to HMG CoA Reductase Inhibitor Therapy, Atherosclerosis 113, 157-166.
32. Lopez-Miranda, J., Ordovas, J.M., Mata, P., Lichtenstein, A.H., Clevidence, B., Judd, J.T., and Schaefer, E.J. (1994) Effect of Apolipoprotein E Phenotype on Diet-Induced Lowering of Plasma Low Density Lipoprotein Cholesterol, J. Lipid Res. 35, 1965-1975.
33. Mackness, M.I., Mackness, B., and Durrington, P.N. (2002) Paraoxonase and Coronary Heart Disease, Atheroscler. Suppl. 3, 49-55.
34. Rantala, M., Silaste, M.L., Tuominen, A., Kaikkonen, J., Salonen, J.T., Alfthan, G., Aro, A., and Kesaniemi, Y.A. (2002) Dietary Modifications and Gene Polymorphisms Alter Serum Paraoxonase Activity in Healthy Women, J. Nutr. 132, 3012-3017.
35. Sanghera, D.K., Aston, C.E., Saha, N., and Kamboh, M.I. (1998) DNA Polymorphisms in Two Paraoxonase Genes (PON1 and PON2) Are Associated with the Risk of Coronary Heart Disease, Am. J. Hum. Genet. 62, 36-44.
36. Herrmann, S.M., Blanc, H., Poirier, O., Arveiler, D., Luc, G., Evans, A., Marques-Vidal, P., Bard, J.M., and Cambien, F. (1996) The Gln/Arg Polymorphism of Human Paraoxonase (PON 192) Is Not Related to Myocardial Infarction in the ECTIM Study, Atherosclerosis 126, 299-303.
37. Ikeda, Y., Suehiro, T., Ohsaki, F., Arii, K., Kumon, Y., and Hashimoto, K. (2003) Relationships Between Polymorphisms of the Human Serum Paraoxonase Gene and Insulin Sensitivity in Japanese Patients with Type 2 Diabetes, Diabetes Res. Clin. Pract. 60, 79-85.
38. Aviram, M., Billecke, S., Sorenson, R., Bisgaier, C., Newton, R., Rosenblat, M., Erogul, J., Hsu, C., Dunlop, C., and La Du, B. (1998) Paraoxonase Active Site Required for Protection Against LDL Oxidation Involves Its Free Sulfhydryl Group and Is Different from That Required for Its Arylesterase/Paraoxonase Activities: Selective Action of Human Paraoxonase Allozymes Q and R, Arterioscler. Thromb. Vasc. Biol. 18, 1617-1624 (1998).
39. Mackness, B., Durrington, P.N., and Mackness, M.I. (1999) Polymorphisms of Paraoxonase Genes and Low-Density Lipoprotein Lipid Peroxidation, Lancet 353, 468-469.
40. Tomás, M., Senti, M., Elosua, R., Vila, J., Sala, J., Masia, R., and Marrugat, J. (2001) Interaction Between the Gln-Arg 192 Variants of the Paraoxonase Gene and Oleic Acid Intake as a Determinant of High-Density Lipoprotein Cholesterol and Paraoxonase Activity, Eur. J. Pharmacol. 432, 121-128.
41. Kuremoto, K., Watanabe, Y., Ohmura, H., Shimada, K., Mokuno, H., and Daida, H. (2003) R/R Genotype of Human Paraoxonase (PON1) Is More Protective Against Lipoprotein Oxidation and Coronary Artery Disease in Japanese Subjects, J. Atheroscler. Thromb. 10, 85-92.
42. Robertson, K.S., Hawe, E., Miller, G.J., Talmud, P.J., and Humphries, S.E. (2003) Human Paraoxonase Gene Cluster Polymorphisms as Predictors of Coronary Heart Disease Risk in the Prospective Northwick Park Heart Study II, Biochim. Biophys. Acta 1639, 203-212 (2003).